Change over period: —
NSE · JUBLINGREA
JUBLINGREA
-23.2% from the 52-week high · +8.4% above the low
Jubilant Ingrevia Ltd. manufactures chemical products. The company is headquartered in Noida, Uttar Pradesh and currently employs 2,293 full-time employees. The company went IPO on 2021-03-19. The firm's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The firm serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
The short version. JUBLINGREA reported revenue of ₹1,394 crore for Sep 2026, up 24.4% from a year earlier. Net profit was ₹111 crore (up 60.9% year on year). Return on equity was 8.9% in Mar 2026. Promoter holding was 45.23% in Sep 2026, down 6.25 points over 8 quarters.
1 · The price
How has the stock traded?
JUBLINGREA trades 23.2% below its 52-week high and 8.4% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹1,394 cr.
Sep 2026 net profit of ₹111 cr.
1.8 pts higher than a year earlier.
Revenue compounded at -2.7% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1394 | 1300 | 1179 | 1051 | 1121 | 1038 | 1051 | 1057 |
| Net profit | 111 | 106 | 86 | 47 | 69 | 75 | 74 | 69 |
| Net margin % | 8.0 | 8.1 | 7.3 | 4.5 | 6.2 | 7.2 | 7.0 | 6.6 |
| EPS (₹) | 7.0 | 6.64 | 5.43 | 2.94 | 4.36 | 4.71 | 4.65 | 4.36 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4388 | 4178 | 4136 | 4773 | 4949 | 684 |
| Net profit | 278 | 251 | 183 | 308 | 477 | 54 |
| Net margin % | 6.3 | 6.0 | 4.4 | 6.4 | 9.6 | 7.9 |
| EPS (₹) | 17.45 | 15.77 | 11.48 | 19.31 | 29.93 | 3.41 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 8.9% in Mar 2026; debt to equity is 0.25.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 8.9 | 8.6 | 6.7 | 11.5 |
| Return on capital % | 10.8 | 11.0 | 9.3 | 14.9 |
| EBITDA margin % | 13.4 | 13.2 | 10.9 | 12.1 |
| Net margin % | 6.3 | 6.0 | 4.4 | 6.4 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -2.7% | 45.2% |
| Profit CAGR | -3.3% | 38.6% |
4 · The owners
Who holds it, and are they adding?
Down 6.25 pts over 8 quarters.
Up 0.05 pts over 8 quarters.
Up 9.18 pts over 8 quarters.
+15 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.48 | 51.48 | 45.23 | 45.23 | 45.23 | 45.23 | 45.23 | 45.23 | -6.25 |
| FII | 6.89 | 7.12 | 6.96 | 5.96 | 6.15 | 6.49 | 6.49 | 6.94 | +0.05 |
| DII | 15.99 | 15.92 | 21.8 | 23.04 | 24.0 | 24.76 | 24.98 | 25.17 | +9.18 |
| Public | 24.9 | 24.76 | 25.29 | 24.93 | 23.81 | 22.52 | 22.29 | 21.69 | -3.21 |
Mutual fund holdings · Oct 2026
78 schemes hold this stock
63 the month before.
- Old Bridge Flexi Cap Fund2.68% of NAV
- DSP Small Cap Fund1.66% of NAV
- Bandhan Innovation Fund1.43% of NAV
- Groww Nifty Chemicals ETF1.41% of NAV
- Kotak Nifty Chemicals ETF1.41% of NAV
- Invesco India Nifty Chemical Index Fund1.38% of NAV
- Unifi Flexi Cap Fund1.32% of NAV
- UTI Small Cap Fund1.31% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for JUBLINGREA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about JUBLINGREA
What is the JUBLINGREA share price?
JUBLINGREA (JUBLINGREA) last closed at ₹573.70, down 2.24% on the day. Its 52-week range is ₹541.30 to ₹763.80.
What is the market cap of JUBLINGREA?
JUBLINGREA has a market capitalisation of about ₹9,233 crore. Its price-to-earnings ratio is 26.7.
How are JUBLINGREA's latest results?
JUBLINGREA reported revenue of ₹1,394 crore for Sep 2026, up 24.4% from a year earlier. Net profit was ₹111 crore (up 60.9% year on year). Return on equity was 8.9% in Mar 2026. Promoter holding was 45.23% in Sep 2026, down 6.25 points over 8 quarters.
Who owns JUBLINGREA?
As of Sep 2026, shareholding was: Promoter 45.23%, FII 6.94%, DII 25.17%, Public 21.69%.
How many mutual funds hold JUBLINGREA?
78 mutual fund schemes held JUBLINGREA in October 2026. That compares with 63 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 10 Feb 2026 · Interim Dividend - Rs. 2.5
- 25 Jul 2025 · Final Dividend - Rs. 2.5
- 03 Feb 2025 · Interim Dividend - Rs. 2.5
- 02 Aug 2024 · Final Dividend - Rs. 2.5
- 09 Feb 2024 · Interim Dividend - Rs. 2.5
- 10 Aug 2023 · Final Dividend - Rs. 2.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.